Delivery Order SPE2DB22D3301-SPE2DB24FZ4AA
Award Date
9/4/24
Potential Completion Date
9/5/24
Potential Value
$2.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Cosentyx (Secukinumab) 300mg dose pens, a specialty pharmaceutical product, at a firm fixed price of $5,595.98. The contract has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Cosentyx (secukinumab) 300 mg dosage pens, a specialty medication used for various medical conditions. The contract has a ceiling value of $21,495.87 and runs through June 27, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,724.90 firm fixed-price contract is for the supply of Cosentyx (secukinumab) 300 mg doses, a specialty medication used to treat certain autoimmune conditions. The contract has an ultimate completion date of April 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cosentyx (Secukinumab) 300 mg pens. The contract has a firm fixed price, a ceiling value of $9,330.31, and a performance period extending until June 5, 2025. The contract is not set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Cosentyx (secukinumab) 300 mg/2 mL injectable pens. The delivery order, valued at $12,175.60, is a firm fixed-price contract with a completion date of September 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these specialty injectable medications to support the medical needs of federal healthcare programs and facilities. This delivery order...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,394.92, is for the supply of Cosentyx (secukinumab) 300 mg doses. It is a firm fixed-price, non-set-aside contract with an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,547.87, is for the delivery of Cosentyx 300 mg dose-2 pen (a specialty medication) and has a completion date of May 10, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $6,087.80 firm fixed-price contract is for the supply of Cosentyx Unoready 300 mg pen 2 ml, a specialty medication. The contract has a completion date of September 5, 2024 and is not designated as a set-aside. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,695.43, is for the delivery of Cosentyx Unoready 300 mg pens, a specialty pharmaceutical product. The contract is a firm fixed-price delivery order with a performance period extending to May 15, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a $3,910.45 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, which has no set-aside designation, covers the supply of Cosentyx (300mg dose) medications to support federal healthcare requirements. AmerisourceBergen is an experienced DLA contractor, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) with the agency to provide a broad range of pharmaceutical products...